IKS Health, a healthcare technology company promoted by Jhunjhunwala family trusts, is set to launch its initial public offering (IPO) on December 12. The IPO is an Offer-for-Sale (OFS), with promoters and existing shareholders offloading 1,87,95,510 shares. The price band is set at ₹1,265-₹1,329 per share, with investors required to bid for a minimum of 11 shares or multiples thereof.
Important Dates:
- IPO Opening Date: December 12, 2024
- IPO Closing Date: December 16, 2024
- Anchor Book Opens: December 11, 2024
- Listing Date: December 19, 2024 (BSE and NSE)
Issue Size: ₹2,497.92 crore
Lot Size: Minimum 11 shares
Company Overview
Incorporated in 2006, Inventurus Knowledge Solutions (IKS Health) offers administrative and technology solutions to healthcare enterprises. The company provides services such as:
- Clinical Support
- Medical Documentation Management
- Virtual Medical Scribing
IKS Health reduces the administrative burden for doctors and healthcare providers, improving patient care delivery. As of September 30, 2024, the company serves 778 healthcare organizations, including major clients like Mass General Brigham, Texas Health Care PLLC, and The GI Alliance Management.
The company operates in the US, Canada, and Australia, providing platforms for outpatient and inpatient healthcare enterprises.
Financial Performance
| Metric | H1 FY25 | FY24 |
|---|---|---|
| Revenue | ₹1,294.61 crore | ₹1,857.94 crore |
| Net Profit | ₹208.58 crore | ₹370.49 crore |
IKS Health has shown robust financial performance, with consistent growth in revenue and profitability.
Investor Participation and Allocation
| Category | Reservation |
|---|---|
| Qualified Institutional Buyers (QIBs) | 75% |
| Non-Institutional Investors (NIIs) | 15% |
| Retail Investors | 10% |
| Employee Reservation | 65,000 shares |
Key promoters and investors participating in the OFS include:
- Ashra Family Trust
- Aryaman, Aryavir, and Nishtha Jhunjhunwala Discretionary Trusts
- Gautam Dhar, Joseph Benardello, Parminder Bolina, Shane Hsuing Peng, Berjis Minoo Desai, and Jeffrey Phillip Freimark
IPO Managers and Listing
Lead Managers: ICICI Securities, Jefferies India, JM Financial, JP Morgan India, and Nomura Financial Advisory
Registrar: Link Intime India
Listing Exchanges: BSE and NSE
Conclusion
The IKS Health IPO offers investors a chance to participate in a growing healthcare technology company with a proven track record. With a robust financial profile and a strong global client base, the IPO is poised to attract significant interest from institutional and retail investors alike.
Click here to know more.
Disclaimer:
This article is for informational purposes only and does not constitute financial advice. Readers should conduct their own research or consult a financial advisor before making investment decisions.
